Press Releases
20 February 2020
SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC) today announced that it has been actively mobilizing resources in a multi-pronged response to the outbreak of novel coronavirus (COVID-19). As part of its efforts, the Company immediately introduced enhanced preventative health meas
Read more...ENGLEWOOD, Colo., Feb. 24, 2020 /PRNewswire/ -- Paragon 28® launched the TenoTac® Soft Tissue Fixation System in January 2019, providing surgeons the first and only dedicated system to address tendon transfers of the forefoot to correct contracted toes and repair plantar plate. In contrast to traditional methods for flexor tendon transfers, TenoTa
Read more...20 February 2020
SANDY SPRINGS, Ga., Feb. 20, 2020 /PRNewswire/ -- Pyramid Family Behavioral Healthcare announced today it plans to open a second adult and adolescent intensive mental health outpatient and partial hospitalization behavioral health treatment program in Sandy Springs, Georgia in March 2020.Pyramid
Read more...20 February 2020
BOSTON, Feb. 20, 2020 /PRNewswire/ -- In response to the growing impact of severe storms and flooding in several Southern U.S. states, Blue Cross Blue Shield of Massachusetts ("Blue Cross") is expanding its offer of expedited access to care to members in Mississippi and
Read more...LA CROSSE, Wis., Feb. 20, 2020 /PRNewswire/ -- The country's most established program for Advance Care Planning (ACP) practice and capacity building, Respecting Choices guides organizations and communities worldwide to effectively implement and sustain evidence-based systems that provide person-centered care."We're honored to be the first advance care planning pr
Read more...SALT LAKE CITY, Feb. 20, 2020 /PRNewswire/ -- ARUP Laboratories announced today that the Food and Drug Administration (FDA) has filed ARUP's premarket approval application (PMA) for an AAV5 total antibody assay. The assay is intended as a companion diagnostic test for valoctocogene roxaparvovec, BioMarin's investigational gene therapy treatment for severe hemophili
Read more...20 February 2020
MECHANICSBURG, Pa., Feb. 20, 2020 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2019.For the fourth quarter ended December 31, 2019, net operating revenues increased 8.7% to $1,374.6 million, compared to
Read more...COLUMBUS, Ga., Feb. 20, 2020 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will present at the Credit Suisse 21st Annual Financial Services Forum. Aflac Incorporated Chairman and Chief Executive Officer Daniel P. Amos will represent the company with a presentation on February 27, 2020
Read more...20 February 2020
WASHINGTON, Feb. 20, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on April 24, 2020 to holders of record on March 27, 2020. In addition
Read more...20 February 2020
ROCKVILLE, Md., Feb. 20, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to dev
Read more...
